The New England journal of medicine, 2017-08, Vol.377 (5), p.419-430
- Khanna, Ashish
- English, Shane W
- Wang, Xueyuan S
- Ham, Kealy
- Tumlin, James
- Szerlip, Harold
- Busse, Laurence W
- Altaweel, Laith
- Albertson, Timothy E
- Mackey, Caleb
- McCurdy, Michael T
- Boldt, David W
- Chock, Stefan
- Young, Paul J
- Krell, Kenneth
- Wunderink, Richard G
- Ostermann, Marlies
- Murugan, Raghavan
- Gong, Michelle N
- Panwar, Rakshit
- Hästbacka, Johanna
- Favory, Raphael
- Venkatesh, Balasubramanian
- Thompson, B. Taylor
- Bellomo, Rinaldo
- Jensen, Jeffrey
- Kroll, Stew
- Chawla, Lakhmir S
- Tidmarsh, George F
- Deane, Adam M
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Khanna, Ashish
- English, Shane W
- Wang, Xueyuan S
- Ham, Kealy
- Tumlin, James
- Szerlip, Harold
- Busse, Laurence W
- Altaweel, Laith
- Albertson, Timothy E
- Mackey, Caleb
- McCurdy, Michael T
- Boldt, David W
- Chock, Stefan
- Young, Paul J
- Krell, Kenneth
- Wunderink, Richard G
- Ostermann, Marlies
- Murugan, Raghavan
- Gong, Michelle N
- Panwar, Rakshit
- Hästbacka, Johanna
- Favory, Raphael
- Venkatesh, Balasubramanian
- Thompson, B. Taylor
- Bellomo, Rinaldo
- Jensen, Jeffrey
- Kroll, Stew
- Chawla, Lakhmir S
- Tidmarsh, George F
- Deane, Adam M
- Titel
- Angiotensin II for the Treatment of Vasodilatory Shock
- Ist Teil von
- The New England journal of medicine, 2017-08, Vol.377 (5), p.419-430
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2017
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Patients with vasodilatory shock were randomly assigned to angiotensin II or placebo. At 3 hours, more patients in the angiotensin II group than in the placebo group had an increase in mean arterial pressure of at least 10 mm Hg or to at least 75 mm Hg.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1704154Titel-ID: cdi_proquest_journals_1925481543
- Format
- –
- Schlagworte
- Aged, Angiotensin, Angiotensin II, Angiotensin II - adverse effects, Angiotensin II - therapeutic use, Blood pressure, Blood Pressure - drug effects, Catecholamines - administration & dosage, Critical care, Death, Double-Blind Method, Drug dosages, Drug therapy, Drug Therapy, Combination, Female, Humans, Hypotension - drug therapy, Intensive care, Male, Middle Aged, Mortality, Norepinephrine, Organ Dysfunction Scores, Shock, Shock - drug therapy, Shock - physiopathology, Vasoconstrictor Agents - adverse effects, Vasoconstrictor Agents - therapeutic use